Want to join the conversation?
$ABT's third quarter adjusted gross margin ratio was 57.5% of sales, up 200 basis points over 2014 and slightly ahead of its forecast driven by continued margin expansion from Diagnostics and Nutrition business. For the fourth quarter 2015, $ABT forecasts its adjusted gross margin ratio to around 59% and adjusted R&D investment to 7%.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.